CFO of Bio-techne Corp (30-Year Financial, Insider Trades) James Hippel (insider trades) sold 24,079 shares of TECH on 07/07/2020 at an average price of $271.59 a share. The total sale was $6.5 million.
Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products. Bio-Techne Corp has a market cap of $10.2 billion; its shares were traded at around $266.75 with a P/E ratio of 56.40 and P/S ratio of 13.89. The dividend yield of Bio-Techne Corp stocks is 0.47%. Bio-Techne Corp had annual average EBITDA growth of 2.20% over the past ten years. GuruFocus rated Bio-Techne Corp the business predictability rank of 3-star. GuruFocus has detected 2 severe warning signs with Bio-Techne Corp. .
CFO Recent Trades:
- CFO James Hippel sold 24,079 shares of TECH stock on 07/07/2020 at the average price of $271.59. The price of the stock has decreased by 1.78% since.
For the complete insider trading history of TECH, click here
.
